Table 1. Patient characteristics and CART details.
Items | Values | ||||
---|---|---|---|---|---|
Age, years | 65.7±12.2 [23–90] | ||||
Sex | |||||
Male | 61 (41.5%) | ||||
Female | 86 (58.5%) | ||||
Primary Diagnoses | |||||
Malignancy | 128 (85.9%) | ||||
Primary site of malignancy | |||||
Liver / Biliary tract | 28 (18.8%) | ||||
Pancreas | 22 (14.8%) | ||||
Stomach | 13 (8.7%) | ||||
Colon-rectum | 9 (6.0%) | ||||
Esophagus | 2 (1.3%) | ||||
Ovary | 38 (25.5%) | ||||
Uterus | 5 (3.4%) | ||||
Others | 11 (7.4%) | ||||
Liver cirrhosis | 17 (11.4%) | ||||
Other illness | 4 (2.7%) | ||||
Complications | |||||
With any complications | 19 (12.9%) | ||||
Details of complications (with redundancy) | |||||
Heart failure | 0 | ||||
Kidney dysfunction | 15 (10.2%) | ||||
Hepatic encephalopathy | 4 (2.7%) | ||||
Esophageal varix | 7 (4.8%) | ||||
Bacterial peritonitis | 0 | ||||
Details of CART procedures | |||||
The number of sessions [session number per patient] | 2.4 ± 2.7 [1–21] | ||||
Session interval [days] | 16.6 ± 25.4 [1–246] |
CART: cell-free and concentrated ascites reinfusion therapy. Numbers in the brackets indicate the ranges.